WillItSurvive

Corti

AI co-pilot that helps clinicians document patient visits in real time.

Losing its protection
Assessed 21 July 2026 · Evidence as of 21 July 2026
The structural protection is eroding.
On the recordSince 21 July 2026 · Checkable from August 2026 · Every call on the record Checkpoint: EU AI Act high-risk medical AI rules take effect
The call

Corti holds narrow regulatory footing in Europe while free tools from OpenAI and Epic squeeze its US market and a three year funding gap raises questions.

Corti sells software that automatically writes down what happens during patient visits by listening to conversations between doctors and patients. The company has real protection in Europe through government approvals and hospital contracts, which is why it still operates there while competitors like OpenEvidence are leaving because of strict EU AI rules. But the core market is getting easier to copy: Epic, which already owns the hospital software that almost every big hospital uses, gave away its own version for free in February 2026, and OpenAI released a free version in May 2026, making it hard for Corti to charge money for something hospitals can get at no cost. The company has not raised new money since September 2023, while its rivals raised billions of dollars, and it faces serious legal problems from a 911 dispatch incident in Seattle, which could cause hospital customers to cancel contracts within months.

Why
01
AI pressure: OpenAI's ChatGPT for Clinicians. Free ChatGPT for Clinicians and Epic's bundled AI Charting undercut Corti's paid documentation tool on price. Could AI do the core job? Yes, likely.
02
Bigger players: Epic Systems. Epic shipped free AI Charting to every hospital on its EHR in Feb 2026, hitting Corti's core market directly. Could a giant copy it? Yes, easily.
03
What protects it. EU and UK device registrations plus NHS contracts give Corti footing in Europe that US rivals can't easily match yet.
What would change this call
Corti announces (or fails to announce) a Series C within 6 months. Clean raise at market terms signals investor confidence; silence or down-round signals distress.
Seattle Fire Department 911 contract outcome after the disclosure scandal. Loss of this contract plus another 911 deal would confirm real customer attrition.
Hospitals' adoption levels of free Epic AI Charting and OpenAI ChatGPT for Clinicians post-launch. Wide free-tool uptake would show Corti's paid product losing ground on price.
Key numbers
  • $60M Series B raised (Sep 2023)
  • ~100-135 employees (2026)
  • ~$16M estimated revenue (2026)
Named risks
  • Seattle 911 AI disclosure scandal and wrongful-death lawsuit could trigger contract loss. Severity: high
  • No new equity round since September 2023 while rivals raise $70M to $250M+. Severity: high
  • Free tools from Epic and OpenAI commoditize core ambient-documentation market. Severity: high
  • EU AI Act compliance execution risk as high-risk rules take effect August 2, 2026. Severity: medium
  • Modest headcount (roughly 100 to 135) and unaudited revenue versus better-funded peers. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
OpenAIgaining onFree 'ChatGPT for Clinicians' launched May 2026; Corti issued rebuttal benchmark May 19, 2026
Epic Systemslosing toFree 'Epic AI Charting' bundled into EHR for all hospital customers, February 2026
Abridgelosing toRaised $250M in February 2024 vs Corti's $60M in September 2023
Microsoft/Nuance Dragon CopilotcontestingGPT-integrated Dragon Copilot, backed by $19.7B Nuance acquisition
Nablagaining onRaised $70M in June 2025 as ambient-scribe market heats up
OpenEvidencecontestingWithdrew from EU/UK markets in 2026 citing EU AI Act, opening space for Corti in Europe
Questions people ask
Is Corti profitable in 2026?
No profitability figures have been disclosed. Corti's last public funding was a $60M Series B on September 20, 2023, and no new equity round has been reported since, despite rivals like Abridge raising $250M in February 2024. Independent revenue data is not available.
Could AI replace Corti's business?
Corti's core product is itself an AI model, so it faces direct commoditization risk. OpenAI launched free 'ChatGPT for Clinicians' in May 2026 and Epic bundled free 'Epic AI Charting' into its EHR in February 2026, both encroaching on Corti's ambient-documentation market.
Who is Corti's biggest competitor?
Corti competes with Abridge, Nabla, Microsoft/Nuance Dragon Copilot, and increasingly Epic Systems and OpenAI, which shipped free competing tools in 2026 (Epic AI Charting, February 2026; ChatGPT for Clinicians, May 2026), pressuring Corti's core ambient-documentation niche.
Has Corti raised new funding recently?
No. Corti's most recent disclosed round is a $60M Series B closed September 20, 2023, co-led by Prosus Ventures and Atomico. As of July 2026, no Series C or follow-on equity round has been publicly announced, a roughly three-year gap.
What is the Seattle 911 controversy involving Corti?
Seattle Times and GeekWire reported on June 14 to 15, 2026 that Seattle Fire Department used Corti's AI on all 911 medical calls since December 2023 without public disclosure, diverting some callers to a Texas nurse line, drawing legal and privacy scrutiny.
Who owns Corti?
Corti is a private, VC-backed Danish company founded in 2016 by CEO Andreas Cleve and CTO Lars Maaloe. No parent company; investors include Prosus Ventures, Atomico, Eurazeo, EIFO and Chr. Augustinus Fabrikker from its September 2023 Series B.
Timeline
  • 2026-07-08Corti launches 'Corti for Startups' program offering up to $5,000 in free API credits
  • 2026-06-14Seattle Times reveals Corti AI used on all Seattle 911 medical calls since Dec 2023, undisclosed
  • 2026-05-19Corti claims Symphony outperforms OpenAI's ChatGPT-for-Clinicians on HealthBench Professional
  • 2026-05-18Corti and BigHand partnership reaches 40,000 NHS workers across 76 trusts
  • 2026-04-01Corti ships Symphony for Medical Coding, claims accuracy edge over major AI labs
  • 2026-02Epic ships free Epic AI Charting bundled into EHR for all hospital customers
  • 2025-09-10Corti partners with Crescendo, deployment claimed across 700+ NHS sites
  • 2025-09Corti secures EU Class I medical device registration for Corti Assistant MD
  • 2025-07Corti secures UK MHRA Class I medical device registration
  • 2023-09-20Corti closes $60M Series B co-led by Prosus Ventures and Atomico
Revision history
21 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources